CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and miceScience Advances2Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. … Continue reading
The ScientistCRISPR Corrects Duchenne-Causing MutationsThe ScientistCardiomyocytes from patients with Duchenne muscular dystrophy (DMD) corrected by CRISPR-Cpf1 reframing during stemness (right) show restored dystrophin expression (red), compared to un… Continue reading
The ScientistCRISPR Corrects Duchenne-Causing MutationsThe ScientistCardiomyocytes from patients with Duchenne muscular dystrophy (DMD) corrected by CRISPR-Cpf1 reframing during stemness (right) show restored dystrophin expression (red), compared to un… Continue reading
Medical Xpress |
Targeting blood vessels to improve cancer immunotherapy
Medical Xpress Cancer immunotherapy aims to enhance or restore the ability of the patient’s immune system – namely T cells – to recognize and attack cancer. But tumors use several strategies to fight back immune attacks, making immunotherapy efficacious only in a … |
|
Cellular Biomedicine Group (CBMG) boosts development of CAR–T and Stem Cell therapies
Scientific Computing World CBMG and GE Healthcare Life Sciences China plan to develop state-of-the-art automated CAR–T and stem cell manufacturing capabilities that build upon the accreditation of CBMG’s GMP facilities in Shanghai, Wuxi and Beijing. The co-development activity … |
Livemint |
DCGI approves Regenerative Medical’s stem cell therapy for cartilage defects
Livemint Mumbai: Regenerative Medical Services Pvt. Ltd on Wednesday said that the Drug Controller General of India (DCGI) recently approved its stem cell-based therapy to treat cartilage defects. Chondron, its cartilage repair procedure, uses the body’s own … |